Literature DB >> 15895001

Genetic testing and the family.

Marcia Van Riper1.   

Abstract

The family experience of genetic testing is explored in this article. Two family stories are presented to illustrate how families define and manage the ethical and social issues that emerge during 2 types of genetic testing: mutation analysis for Huntington's disease and genetic testing for breast and ovarian cancer susceptibility. These 2 families were purposefully selected because their stories exemplify the complexity of the genetic testing experience. In addition, the story of the family living with Huntington's disease shows how negative consequences can occur for the individual tested, other family members, the marital relationship, and the family system, even when the test results indicate that the individual does not carry a deleterious gene mutation. Both of the families presented in this article participated in an ongoing study, Family Experience of Genetic Testing: Ethical Dimensions , in which 118 family members from 67 families have participated. The guiding framework for this research was the family management style framework developed and refined by Knafl and colleagues.

Entities:  

Mesh:

Year:  2005        PMID: 15895001     DOI: 10.1016/j.jmwh.2005.02.008

Source DB:  PubMed          Journal:  J Midwifery Womens Health        ISSN: 1526-9523            Impact factor:   2.388


  6 in total

1.  Unpacking the blockers: understanding perceptions and social constraints of health communication in hereditary breast ovarian cancer (HBOC) susceptibility families.

Authors:  June A Peters; Regina Kenen; Lindsey M Hoskins; Laura M Koehly; Barry Graubard; Jennifer T Loud; Mark H Greene
Journal:  J Genet Couns       Date:  2011-05-06       Impact factor: 2.537

Review 2.  Points to Consider: Ethical, Legal, and Psychosocial Implications of Genetic Testing in Children and Adolescents.

Authors:  Jeffrey R Botkin; John W Belmont; Jonathan S Berg; Benjamin E Berkman; Yvonne Bombard; Ingrid A Holm; Howard P Levy; Kelly E Ormond; Howard M Saal; Nancy B Spinner; Benjamin S Wilfond; Joseph D McInerney
Journal:  Am J Hum Genet       Date:  2015-07-02       Impact factor: 11.025

3.  Looking for Trouble: Preventive Genomic Sequencing in the General Population and the Role of Patient Choice.

Authors:  Gabriel Lázaro-Muñoz; John M Conley; Arlene M Davis; Marcia Van Riper; Rebecca L Walker; Eric T Juengst
Journal:  Am J Bioeth       Date:  2015       Impact factor: 11.229

Review 4.  Genetic testing for potentially lethal, highly treatable inherited cardiomyopathies/channelopathies in clinical practice.

Authors:  David J Tester; Michael J Ackerman
Journal:  Circulation       Date:  2011-03-08       Impact factor: 29.690

5.  Social and Cultural Elements Associated with Neurocognitive Dysfunctions in Spinocerebellar Ataxia Type 2 Patients.

Authors:  Roberto Emmanuele Mercadillo; Víctor Galvez; Rosalinda Díaz; Lorena Paredes; Javier Velázquez-Moctezuma; Carlos R Hernandez-Castillo; Juan Fernandez-Ruiz
Journal:  Front Psychiatry       Date:  2015-06-10       Impact factor: 4.157

6.  "What does it mean?": uncertainties in understanding results of chromosomal microarray testing.

Authors:  Marian Reiff; Barbara A Bernhardt; Surabhi Mulchandani; Danielle Soucier; Diana Cornell; Reed E Pyeritz; Nancy B Spinner
Journal:  Genet Med       Date:  2012-01-05       Impact factor: 8.822

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.